Blood Test Predicts Who Benefits from Hydrogen Therapy for Autoimmune Disease
Predicting Therapeutic Response to Molecular Hydrogen in Autoimmune Diseases via Immunophenotyping
Research hubs: Rheumatoid Arthritis · Immune System · Musculoskeletal System
- Evidence type
- Uncontrolled trial (single-arm or pilot) · Human study
- Authors
- Shan-Wen Lui, Ting-Yu Hsieh, Jeng-Wei Lu, Yi-Jung Ho, Feng-Cheng Liu
- Journal
- APMIS
- Year
- 2025
- PMID
- 40590161
- Study Type
- Human
- Participants
- 25
- Delivery
- Gas
- Dose
- 170 mg hydrogen-enriched coral calcium daily for three months
- Duration
- 3 months
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 1 (OpenAlex, as of November 2026)
- Country
- Taiwan
TL;DR
Hydrogen therapy altered immune cell activity in autoimmune patients and helped reduce fatigue, especially in those with favorable immune profiles.
Key Finding
Molecular hydrogen therapy produced disease-specific changes in immune cells, with rheumatoid arthritis patients showing increased PD-1+ T cells and Fas+ B cells, and a newly developed prediction index (HRPI) showed strong ability to identify which patients would respond favorably to treatment.
Summary
This study examined how molecular hydrogen therapy affects the immune system in 25 patients with autoimmune diseases like rheumatoid arthritis and lupus. Researchers tracked changes in immune cells before and after three months of hydrogen-enriched coral calcium supplements and found that certain immune cell types changed differently depending on the disease. They also developed a prediction tool that uses baseline immune cell patterns and fatigue levels to forecast which patients would respond well to the treatment.
Practical Takeaway
This small human study suggests molecular hydrogen may have immunomodulatory effects in autoimmune diseases and that baseline immune testing might help predict treatment response. However, the study is preliminary with a small sample size (25 patients) and lacks a placebo control group, so these findings require validation in larger, more rigorous trials before drawing conclusions about clinical benefit.
Abstract (excerpt)
ABSTRACT Autoimmune diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), are characterized by immune dysregulation that leads to chronic inflammation and organ damage. Current therapeutic strategies—including corticosteroids, immunosuppressants, and biologics—often…